Laser panretinal photocoagulation (PRP) reduces visual loss in proliferative diabetic retinopathy but decreases peripheral retinal function. The Driver and Vehicle Licensing Centre (DVLC) states that when a patient volunteers that he or she has had photocoagulation, a questionnaire will then be sent to the patient's diabetic physician who can refer the patient for formal field test ing. Of 30 patients who had PRP, 15 failed DVLC visual field regulations using the Esterman binocular field test on the Humphrey field analyser. The failures were more likely to have had treatment with a xenon laser, but there was no difference between the groups as regards age, number of burns or whether an argon or diode laser was use«J. The patients who failed were more likely to be hypertensive (p = 0.04). Two patients with unilateral PRP could not meet the driving regulations because of other field defects. Diabetes itself causes field defects, and therefore even with small amounts of laser, formal field testing may be necessary.
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Laser pametinal photocoagulation (PRP) is known to reduce the risk of severe visual loss in diabetic prolifer ative retinopathy.! However, PRP causes visual field loss and reduced peripheral retinal functionY Driver and Vehicle Licensing Centre (DVLC) regulations now require a diabetic who has had laser treatment to have a binocular visual field of 120° along the horizontal with 20° above and below this horizontal line. The fields can be done on a variety of perimeters, either kinetic or static. Guidelines have been issued by the DVLC as to the para meters needed for each type of field testing equipment used.4
METHOD
Thirty diabetics who had had full PRP with either a xenon arc, argon or diode laser, or combinations of these modal ities, had their fields tested on the Humphrey field ana lyser, an automated static perimeter. The program used was the Esterman binocular field program which assessed the binocular visual field in accordance with DVLC regulations.4 All patients had had laser treatment at least 2 months previously and all were considered to have had successful regression of their proliferative retinopathy. Any patients who failed were given a second test a few weeks later, to allow for any learning or fatigue effect.5 Patients who were unexpected failures also had uniocular full visual field analysis to analyse why they had failed. The two groups of patients, those that failed and those that passed, were then looked at in terms of laser type, number and size of bums, choroidal pigmentation, sex, age, diabetic age, insulin dependence, blood pressure, nephropathy and neuropathy, to see whether any factors affected which group a patient was likely to fall into. Choroidal pig mentation was assessed by grading fundus photographs taken prior to PRP from 1 to 5, with 1 being a 'blond' fun dus and 5 a heavily pigmented fundus. Patients were con sidered to be hypertensive if they were either taking antihypertensive drugs or had consistent blood pressure measurements equal to or greater than 150/90 mmHg, the level usually used to define adult hypertension.6 Neph ropathy was present if the patient had either proteinuria, a raised creatinine level or a kidney transplant. Absent reflexes, loss of vibration sense or autonomic problems indicated diabetic neuropathy.
RESULTS
Of the 30 PRP patients, 15 failed the Humphrey binocular driving field test. Most had a reasonable horizontal field of up to 80°, but outside this those that failed could not achieve the required 20° of visual field above and below the horizontal. A certain amount of leniency was applied, with the patient being passed when isolated scotomas just prevented the full width of the required field being obtained. If these cases were also to have been considered failures, then the total failures would have been 19 out of 30 patients, ie 63%.
There was no statistically significant difference between the two groups regarding any of the systemic fac tors listed in Table I with the exception of blood pressure. There was an increased chance of failure in patients who either had blood pressure readings over 150/90 mmHg or were on antihypertensive treatment (p = 0.04). This was less likely when only those with blood pressure greater than 150/90 mmHg were considered (p = 0.08). , The definition of hypertension in these groups included patients on antihypertensive therapy, and also those who had a blood pressure equal to or more than 150/90 mmHg on three consecutive occasions. Five patients had had xenon treatment, and of these 4 failed and 1 passed. Excluding the xenon-treated patients, there was no difference in the total number of laser bums given or the average bum size. There was also no differ ence between the two groups in the relative proportions and number of bums of diode or argon used (Table II) . Twenty-six eyes had been treated with argon alone. Not enough patients had been treated by diode alone to allow direct comparisons, but 16 eyes had been treated with 50% diode and 50% argon. On average it took 1832 argon bums to induce regression compared with 2430 of the argon/ diode combination. This was not a statistically significant difference (p = 0.18).
Of the 15 diabetics who passed DVLC regulations, 12 had had bilateral PRP and 3 unilateral. Of the 15 who failed, 13 had had bilateral PRP and 2 unilateral. In all the failures where only one eye had been lasered, the patients were unable to complete the binocular field test success fully because of field defects documented on full periph eral field analysis in the other eye.
DISCUSSION
Xenon arc, diode and argon laser are the three methods of photocoagulation used in the diabetics assessed. Xenon arc emits white light from 350 to 1600 nm which is Comparisons of the groups who passed and failed the field test show no difference between groups in the number of argon and diode bums or the bum size. A factor which can not be assessed directly is the severity of the bums at time of PRP. It is known that visual field loss is more prevalent in eyes treated with intense spots of high energy when compared with eyes treated with similar sized moderate bums. \0 In our two groups there is an equal scatter of blond to pigmented fundi, with apparently no relationship to visual field outcome. This suggests that despite the greater diffi culty in obtaining visible bums in blond fundi, there is no associated increased risk of visual field loss. Excluding patients who had had xenon treatment, since this is a known risk factor for field loss, there is a greater incidence of hypertension in those patients who failed the DVLC regulations (p = 0.04). However, it must be borne in mind that this is a small sample and further studies will be needed to confirm these findings.
Two patients could not fulfil the DVLC criteria despite having only one eye lasered. This is due to profound field defects in the lasered eye combined with previously unknown defects, superiorly and nasally, in the non lasered eye. Other studies have shown that even with at most moderate retinopathy and no laser treatment, dia betics can lose significant visual field presumably secon dary to subclinical microangiopathy. II Several studies indicate an association between hypertension and the development and progression of diabetic retinopathy.12 The field defects in our patients may have been present to some degree prior to laser treatment.
Field loss is probably multifactorial and it should not be assumed that just because a patient has had only one eye lasered, or even has had no laser treatment at all, that he or she will fulfil the legal driving requirements without for mal field testing.
